Y. Yi

发表

Implications of driver genes associated with a high tumor mutation burden identified using next-generation sequencing on immunotherapy in hepatocellular carcinoma

Chao Meng, Xiaosong Rao, Li Li, 2020, Oncology letters.

Newborn hearing concurrent genetic screening for hearing impairment-a clinical practice in 58,397 neonates in Tianjin, China.

X. Yi, J. Zou, B. Han, 2013, International journal of pediatric otorhinolaryngology.

Characteristics and Management of TP53-Mutated Diffuse Large B-Cell Lymphoma Patients

Yuankai Shi, P. Liu, Jian-liang Yang, 2020, Cancer management and research.

Analysis of MET kinase domain rearrangement in NSCLC.

N. Wu, M. Zhuo, Jun Zhao, 2020, Lung cancer.

A Reference System for BRCA Mutation Detection Based on Next-Generation Sequencing in the Chinese Population.

X. Yi, K. Shao, Y. Guan, 2019, The Journal of molecular diagnostics : JMD.

A retrospective case study of sunitinib treatment in three patients with Von Hippel-Lindau disease

X. Yi, Y. Guan, Luofu Wang, 2018, Cancer biology & therapy.

A novel BRCA2 mutation in prostate cancer sensitive to combined radiotherapy and androgen deprivation therapy

X. Yi, Y. Guan, Jun Jiang, 2018, Cancer biology & therapy.

A novel BRCA2 mutation in prostate cancer sensitive to combined radiotherapy and androgen deprivation therapy

X. Yi, Y. Guan, Jing Xu, 2018, Cancer biology & therapy.

CMAR_A_269624 11515..11522

P. Liu, Jian-liang Yang, Sheng Yang, 2020 .

Novel genotype–phenotype correlations in five Chinese families with Von Hippel–Lindau disease

X. Yi, Y. Guan, Luofu Wang, 2018, Endocrine connections.

6-5-2018 Novel Genotype-Phenotype Correlations in Five Chinese Families with Von Hippel-Lindau Disease

X. Yi, Y. Guan, Luofu Wang, 2018 .

Maximum Somatic Allele Frequency-Adjusted Blood-Based Tumor Mutational Burden Predicts the Efficacy of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer

X. Yi, Xiao Chen, Y. Guan, 2022, Cancers.

A novel mutation in the SRY gene of a Chinese 46, XY female patient with unilateral mixed germ cell tumor

X. Yi, Li-jie Song, Tao Liu, 2016 .

Targeted next-generation sequencing identification of mutations in patients with disorders of sex development

Asan, X. Yi, Changxin Gao, 2016, BMC Medical Genetics.

The prevalence of HLA‐I LOH in Chinese pan‐cancer patients and genomic features of patients harboring HLA‐I LOH

Y. Guan, Xiaorui Fu, Zeyi Liu, 2021, Human mutation.

Thyroid follicular carcinoma-like renal tumor

X. Yi, Y. Guan, Yaoming Li, 2018, Medicine.

Clinical and genomic features of Chinese lung cancer patients with germline mutations

X. Yi, Y. Guan, Ling Yang, 2019, Nature Communications.

Prevalence of recurrent oncogenic fusion in mismatch repair-deficient colorectal carcinoma with hypermethylated MLH1 and wild-type BRAF and KRAS

P. A. Futreal, X. Yi, S. Kopetz, 2019, Modern Pathology.

Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer

P. A. Futreal, X. Yi, I. Wistuba, 2018, Nature Communications.

Genotyping of Circulating Tumor DNA Reveals the Clinically Actionable Mutation Landscape of Advanced Colorectal Cancer

X. Yi, Yuhua Gong, Y. Guan, 2019, Molecular Cancer Therapeutics.

Carney Complex with PRKAR 1 A Gene Mutation : A Case Report and Literature Review

X. Yi, Y. Guan, Yaoming Li, 2018 .

Next-generation Sequencing Reveals Age-dependent Genetic Underpinnings in Lung adenocarcinoma

Lin Li, Y. Guan, Ling Yang, 2022, Journal of Cancer.

Detection of inherited mutations for hereditary cancer using target enrichment and next generation sequencing

X. Yi, Y. Bignon, Yuhua Gong, 2014, Familial Cancer.

HIF2A germline–mutation-induced polycythemia in a patient with VHL-associated renal-cell carcinoma

X. Yi, Y. Guan, Yaoming Li, 2017, Cancer biology & therapy.

Comprehensive carrier genetic test using next-generation deoxyribonucleic acid sequencing in infertile couples wishing to conceive through assisted reproductive technology.

Nicolas Garrido, Huiqian Du, Asan, 2015, Fertility and sterility.

Application of next-generation sequencing in clinical oncology to advance personalized treatment of cancer

Y. Guan, Ling Yang, Y. Yi, 2012, Chinese journal of cancer.

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing.

X. Yi, Meiru Zhao, Y. Guan, 2017, Journal of visualized experiments : JoVE.

Germline SDHB and SDHD mutations in pheochromocytoma and paraganglioma patients

Luofu Wang, Jun Jiang, Jian Pang, 2018, Endocrine connections.

Genomic Alterations and MYD88MUT Variant Mapping in Patients with Diffuse Large B-Cell Lymphoma and Response to Ibrutinib

Peng Liu, Yuankai Shi, Biao Liu, 2020, Targeted Oncology.

An EGFR L858R mutation identified in 1862 Chinese NSCLC patients can be a promising neoantigen vaccine therapeutic strategy

Yu Chen, X. Yi, Jun Liu, 2022, Frontiers in Immunology.

Liquid biopsy in diffuse large B-cell lymphoma: utility in cell origin determination and survival prediction in Chinese patients

Ling Yang, Jun Zhu, Weiping Liu, 2021, Leukemia & lymphoma.

Author Correction: Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer

P. A. Futreal, X. Yi, I. Wistuba, 2019, Nature Communications.

Construction and Validation of a Platinum Sensitivity Predictive Model With Multiple Genomic Variations for Epithelial Ovarian Cancer

Y. Guan, T. Shu, X. Xia, 2021, Frontiers in Oncology.

Next-generation sequencing reveals heterogeneous genetic alterations in key signaling pathways of mismatch repair deficient colorectal carcinomas

Yangzhige He, Huanwen Wu, Jing Wang, 2020, Modern Pathology.

Circulating Tumor DNA: Less Invasive, More Representative Method to Unveil the Genomic Landscape of Newly Diagnosed Multiple Myeloma Than Bone Marrow Aspirates

R. Fu, Xiaojun Huang, Jin Lu, 2022, Cancers.

Targeted High-Throughput Sequencing Identifies Pathogenic Mutations in KCNQ4 in Two Large Chinese Families with Autosomal Dominant Hearing Loss

X. Yi, Ling Yang, L. Lan, 2014, PloS one.

P2.04-54 Characteristic of MSI-H Lung Cancer Patients Identified with Targeted Next-Generation Sequencing

Y. Guan, X. Xia, G. Lin, 2019, Journal of Thoracic Oncology.

Comprehensive analysis of oncogenic fusions in mismatch repair deficient colorectal carcinomas by sequential DNA and RNA next generation sequencing

Xiao-Ding Liu, Junjie Li, Huanwen Wu, 2021, Journal of Translational Medicine.

Detection of inherited mutations for hereditary cancer using target enrichment and next generation sequencing

X. Yi, Y. Bignon, Yuhua Gong, 2015, Familial Cancer.

The prevalence of HLA‐I LOH in Chinese pan‐cancer patients and genomic features of patients harboring HLA‐I LOH

Y. Guan, Xiaorui Fu, Zeyi Liu, 2021, Human mutation.

The prevalence of HLA LOH across 10 cancer types in Chinese patients.

Y. Guan, F. Tong, Xiaorui Fu, 2020 .